With the rising global prevalence of conditions like pre-diabetes and type 2 diabetes, understanding how the gut microbiome influences glucose control can offer new possibilities for clinical care. Growing research indicates that the gut microbiota, particularly through the production of short-chain fatty acids (SCFAs), plays a role in managing blood sugar levels and supporting insulin sensitivity. Here’s what general practitioners need to know about leveraging gut health in diabetes prevention and management.
Studies reveal that individuals with pre-diabetes or type 2 diabetes mellitus (T2DM) often have imbalances in their gut microbiota compared to healthy individuals [1]. A 2022 study from Finland examined 5,572 adults and found a connection between gut microbiome composition and the onset of type 2 diabetes, which could enhance the ability to predict the disease’s development [2].
Patients with T2DM exhibit a reduced abundance of butyrate-producing bacteria, which play an essential role in SCFA production. SCFAs, including butyrate, act as metabolic signals that influence glucose homeostasis by promoting insulin sensitivity and reducing inflammation [3]. Beyond microbiome composition, dysbiosis in T2DM can contribute to chronic low-grade inflammation, which contributes to insulin resistance by disrupting insulin signaling pathways.
Additionally, a diverse microbiota appears essential for metabolic health, as greater microbial diversity is associated with better glucose regulation and a reduced risk of insulin resistance [3]. Research on SCFA supplementation has also shown promise: in T2DM patients, it not only boosted butyrate-producing bacteria but also led to favorable outcomes, such as increased GLP-1 secretion and improved hemoglobin A1c levels [4]. These findings highlight the potential of microbiome-targeted strategies in diabetes care.
Diet plays a significant role in shaping the health and composition of the gut microbiome and its metabolites. A diet rich in fibre (from fruits, vegetables, legumes, and whole grains) provides essential fuel for beneficial gut bacteria, promoting SCFA production and stabilising blood sugar levels. Studies show that dietary fibre is associated with increased butyrate production and improved insulin sensitivity, underscoring its role as a cornerstone in diabetes management [5]. Additionally, lifestyle factors such as physical activity, stress management, and quality sleep further support gut health.
As research continues to expand, diet and lifestyle interventions are emerging as valuable additions to traditional diabetes management. Gut-friendly dietary changes offer general practitioners an evidence-based approach for supporting patients’ blood sugar levels. By promoting fibre-rich and diverse diets alongside balanced lifestyle habits, doctors can empower patients with tools to optimise both their gut and metabolic health.
– Sarah Marko, Accredited Practising Dietitian
Learn more with HealthCert's online courses in Clinical Nutrition.
Read another article in Clinical Nutrition.
|
|
|
References
[1] Kreznar JH, Keller MP, Traeger LL, Rabaglia ME, Schueler KL, Stapleton DS, Zhao W, Vivas EI, Yandell BS, Broman AT, Hagenbuch B, Attie AD, Rey FE. Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes. Cell Rep. 2017 Feb 14;18(7):1739-1750. doi: 10.1016/j.celrep.2017.01.062. PMID: 28199845; PMCID: PMC5325228.
[2] Matti O. Ruuskanen, Pande P. Erawijantari, Aki S. Havulinna, Yang Liu, Guillaume Méric, Jaakko Tuomilehto, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen; Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults. Diabetes Care 1 April 2022; 45 (4): 811–818. https://doi.org/10.2337/dc21-2358
[3] Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012 Oct 4;490(7418):55-60. doi: 10.1038/nature11450. Epub 2012 Sep 26. PMID: 23023125.
[4] Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L, Xu C, Ren Z, Xu Y, Xu S, Shen H, Zhu X, Shi Y, Shen Q, Dong W, Liu R, Ling Y, Zeng Y, Wang X, Zhang Q, Wang J, Wang L, Wu Y, Zeng B, Wei H, Zhang M, Peng Y, Zhang C. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018 Mar 9;359(6380):1151-1156. doi: 10.1126/science.aao5774. PMID: 29590046.
[5] Mayorga-Ramos A, Barba-Ostria C, Simancas-Racines D, Guamán LP. Protective role of butyrate in obesity and diabetes: New insights. Front Nutr. 2022 Nov 24;9:1067647. doi: 10.3389/fnut.2022.1067647. PMID: 36505262; PMCID: PMC9730524.